DENDREON Stock Price
$3.885 
Change:
-0.04 -0.45% Volume:
120,919
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 3.92 | Todays Low: 3.86 | Open: 3.92 | Last Close: 3.905
52 Wk High: 7.94 | 52 Wk Low: 3.7 | Todays Pivot: 3.89 | Pre market open: 3.92
Sector: Healthcare and Pharmaceuticals
Related Healthcare and Pharmaceuticals Companies
Above is a small selection of related companies to Dendreon which compete alongside DNDN within the Healthcare and Pharmaceuticals sector.
Online News For Dendreon
|
'Brazen Fraud' Alleged at Dendreon Corp. - Courthouse News Service
Wed, 22 May 2013 15:24SEATTLE (CN) - Directors of Dendreon Corp. committed "brazen fraud" by dumping $85 million of their own shares at inflated prices while falsely claiming its expensive cancer drug Provenge was "completely sold out," shareholders claim in court ...
|
|
Dendreon Analysts Getting Very Skeptical - Seeking Alpha
Wed, 22 May 2013 12:51It's been a couple of weeks now since Dendreon (DNDN) reported an absolute train wreck first quarter. Revenues plunged, cash burn was extreme, and doubts over the company's future increased. Now that we've had some time to fully digest the results, I'm ...
|
|
Bernstein Litowitz Berger & Grossmann LLP Announces Proposed Settlement in ... - MarketWatch (press release)
Wed, 22 May 2013 16:01If you purchased or otherwise acquired Dendreon common stock at any time between April 29, 2010 and August 3, 2011, inclusive, and were damaged thereby, you may be potentially eligible to share in the distribution of the settlement fund if you submit a ...
|
|
Dendreon says competition hurt 1Q Provenge sales - NBCNews.com
Thu, 09 May 2013 17:55SEATTLE — Dendreon Corp. said Thursday that sales of its prostate cancer therapy Provenge fell in the first quarter because of increased competition from two newer drugs. Don't miss these Health stories. EXCLUSIVE: Marcheline Bertrand, French actress ...
|
|
Dendreon: Picking Through the Carnage - Motley Fool
Sat, 11 May 2013 20:00Dendreon has had some ugly quarters before. In fact, earnings have generally been a house of pain for investors in the company. Most of the big stock drops seen since launching prostate cancer vaccine Provenge have coincided with disappointing sales ...
|
|
Will Dendreon Ever Make Money? - Motley Fool
Tue, 07 May 2013 14:42On Thursday, Dendreon (NASDAQ: DNDN ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to ...
|
DNDN Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Dendreon quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for DNDN to choose from. Visit here to build your stock quote widget »
